FEB 27, 2020 11:00 AM PST

New Drug Shows Promise in Treating Chronic Cough

WRITTEN BY: Annie Lennon

Between 4% and 10% of adults around the world have an unexplainable chronic cough that has lasted for over 8 weeks. Although no treatments are currently available, a drug developed by Afferent Pharmaceuticals known as Gefapixant has shown promise as a potential treatment in a company-funded Phase 2b trial. 

In the study, a total of 253 patients suffering from a chronic cough for an average of 14.5 years were randomly assigned to either receive Gefapixant or a placebo (63 patients) twice daily for 84 days. Under double-blind conditions across 44 sites between the UK and US, the drug was administered in one of three doses: 7.5 mg (64 patients), 20 mg (63 patients) or 50 mg (63 patients). The frequency of each patient’s coughing was then recorded both by patients in their diaries and by sound recording devices over four 24-hour periods. 

Prior to the treatment,  each of the patients coughed between 24 and 29 times per hour. After the 12-week trial however, the researchers found that while the placebo group coughed an average of 18 times per hour, those in the 50 mg Gefapixant dose group coughed just 11 times per hour. Meanwhile, results from the other two dosage groups of the drug were deemed insignificant. 

Although a distorted sense of taste alongside other taste-related side effects saw 10 patients (16%) in the 50 mg group withdraw from the trial, the majority of the remaining participants said they were satisfied with the drug’s effects, and so would gladly continue to take it for at least another year. 

Based on these results, the researchers have already organized a series of Phase 3 trials with a larger group of people to be monitored over a longer period of time. Principle researcher of the study, Professor Jacky Smith from the University of Manchester, UK said, “This drug has exciting prospects for patients who suffer from the often distressing condition of chronic cough...Effective treatments for cough are a significant unmet clinical need and no new therapies approved in over 50 years...Effective treatments for cough are a significant unmet clinical need and no new therapies approved in over 50 years.”


Sources: Pharmaceutical Technology, Medscape and BBC

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUL 10, 2020
Drug Discovery & Development
Injection 66% Better than Daily Pill to Prevent HIV
JUL 10, 2020
Injection 66% Better than Daily Pill to Prevent HIV
Pharmaceutical company ViiV Healthcare has announced that its long-lasting, injectable drug, cabotegravir, is more effec ...
JUL 15, 2020
Cancer
Traditional Medicine Reveals a New Anti-Cancer Drug
JUL 15, 2020
Traditional Medicine Reveals a New Anti-Cancer Drug
The art of traditional eastern medicine dates back thousands of years. It uses many unproven remedies, and many consider ...
JUL 17, 2020
Drug Discovery & Development
Could Low-Dose Radiation Therapy Treat COVID-19?
JUL 17, 2020
Could Low-Dose Radiation Therapy Treat COVID-19?
Research from a century ago points towards the potential of low-dose radiation therapy (LDRT) for treating pneumonia. Ev ...
JUL 26, 2020
Drug Discovery & Development
Seaweed Extract Outperforms Remdesivir in Blocking COVID-19
JUL 26, 2020
Seaweed Extract Outperforms Remdesivir in Blocking COVID-19
An extract from seaweed has outperformed Remdesivir in ousting COVID-19 during cellular tests, according to new research ...
JUL 07, 2020
Drug Discovery & Development
Software That Finds Drug-Resistant Bacteria
JUL 07, 2020
Software That Finds Drug-Resistant Bacteria
Finding drug-resistant genes in bacteria remains a challenge. However, scientists at Washington State University have de ...
JUL 29, 2020
Health & Medicine
New Study to Put Medical Cannabis to a Proper Test
JUL 29, 2020
New Study to Put Medical Cannabis to a Proper Test
Real world use of medical cannabis is going to be put to the test in a first-of-its-kind study that should add a lo ...
Loading Comments...